Carlsen is on the board of PTC Therapeutics and Santaris Pharma, and was previously a board member of 7TM Pharma and Arpida.

The University of Cambridge is making its first three investments into UoC spinouts through its new Enterprise Fund.

Complex buyout by Nasdaq listed Global Eagle Acquisition Corporation of two inflight entertainment companies, was proceeded by a minority stake buy by one company in the other in June.

Nanomedicine firm Nanobiotix, a spinoff from the University of Buffalo, raises $18.1m in its initial public offering.

Read say: "Digital is now something like 30% of revenue [at WPP] and Paidcontent ranked us number seven in its list of the top global digital media businesses. What we are trying to do is digitise the group."

"I care for the commercial side, Claus [Schmidt, another managing director] for the technical side."

Schwegler joined T-Venture in October 2000 and was initially responsible for the INI-Ventures Fund and research and analysis, before taking over the management of the new T-Com Venture Fund in 2004 and becoming chief executive a year later.

San Francisco-based Reinemann is hopeful his role will significantly modernise the bank.